| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/18/2005 | CN1617850A Dibenzylamine compound and medicinal use thereof |
| 05/18/2005 | CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 05/18/2005 | CN1617755A Fpt inhibitor and use of other anti-tumor agent in combination in preparing anticancer drug |
| 05/18/2005 | CN1617744A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 05/18/2005 | CN1617737A Compositions and method for normalizing lipid levels in mammalian tissues |
| 05/18/2005 | CN1617729A Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia |
| 05/18/2005 | CN1617727A Selective dopamin D3 receptor agonists for the treatment of sexual dysfunction |
| 05/18/2005 | CN1617726A N4-acylcytosine nucleosides for treatment of viral infections |
| 05/18/2005 | CN1617725A Tyrosyl derivatives and their use as P2X7 receptor modulators |
| 05/18/2005 | CN1617723A Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 05/18/2005 | CN1617722A Nicotin-or isonicotin benzothiazole derivatives |
| 05/18/2005 | CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 05/18/2005 | CN1617719A Combination comprising a P-GP inhibitor and an anti-epileptic drug |
| 05/18/2005 | CN1617717A Pharmaceutical compositions of amlodipine and atorvastatin |
| 05/18/2005 | CN1617712A Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 05/18/2005 | CN1617711A Liposomal delivery of vitamin E based compounds |
| 05/18/2005 | CN1617710A Liposome composition for delivery of nucleic acid |
| 05/18/2005 | CN1617704A Composition comprising at least one oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 05/18/2005 | CN1617703A Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof |
| 05/18/2005 | CN1617702A Product containing an extract of red algae of the genus porphyra and methods for protecting cells |
| 05/18/2005 | CN1617691A Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/18/2005 | CN1616432A Compound, its use and pharmaceutical compositions comprising same |
| 05/18/2005 | CN1616425A Noval benzoindoline compounds, their preparing method and pharmaceutical composition containing them |
| 05/18/2005 | CN1616422A Disulfide derivatives useful for treating allergic diseases |
| 05/18/2005 | CN1616386A Intermediate for preparing isothiazole derivatives |
| 05/18/2005 | CN1616106A Method for preparing biological preparation for improving pig growth |
| 05/18/2005 | CN1616079A Chinese medicine for fat reducing and long life |
| 05/18/2005 | CN1616070A Local external application medicine for treating appendicitis and preparing method |
| 05/18/2005 | CN1616020A Xingnaojing powder injection and preparing method |
| 05/18/2005 | CN1616005A Compound brain tonifying and intellect strengthening gastrodia tuber capsule |
| 05/18/2005 | CN1615981A Rhizoma alismatis new use discovered by toadstool choline M1 receptor prot-agonist screening technology |
| 05/18/2005 | CN1615961A Concentratend liuweidihuang lozenge and its preparing method |
| 05/18/2005 | CN1615946A Anti-senility plaster |
| 05/18/2005 | CN1615910A Medicine for treating coronary heart disease and angina pectoris and restenosis after intervention operation |
| 05/18/2005 | CN1615890A Use of vitamin d compounds |
| 05/18/2005 | CN1615880A Combined agents for treatment of glaucoma |
| 05/18/2005 | CN1615879A Combined agents for treatment of glaucoma |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1615861A (1s, 2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
| 05/18/2005 | CN1202257C Recombination carrier and treating composition used in insulin dependent diabetes gene curing |
| 05/18/2005 | CN1202130C Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method |
| 05/18/2005 | CN1202123C Crystalline forms of IS-[la(pha(2S, 3R),9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl) carbonyl]-amino] actahydro-6H-piridazino [1,2-A] [1,2] diazepin-1-carboxamide |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1202081C Amidino and guanidino bita-azetidinone tryptase inhibitors |
| 05/18/2005 | CN1202078C Method of producing n-(4,5-bis-(methanesulfonyl)-2-methyl-benzoyl)-guanidine, hydrochloride and its preparing method |
| 05/18/2005 | CN1201820C Compositions containing benzimidazolones and progestogens |
| 05/18/2005 | CN1201816C Pharmaceutical formulations for IGF/IGFBP |
| 05/18/2005 | CN1201814C Treatment of cardiao megaly |
| 05/18/2005 | CN1201812C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 05/18/2005 | CN1201811C Chinese medicine composition for treating myopia and preparing method thereof |
| 05/18/2005 | CN1201788C Medical composition possessing function of refreshing oneself, senium-resistant, reinforcing body fluid and nourishing the blood, nourishing liver and preparing method |
| 05/18/2005 | CN1201773C Wind dispelling oil and producing process |
| 05/18/2005 | CN1201770C Chinese medicin preparation for treating heart obstruction and preparation technology |
| 05/18/2005 | CN1201758C Chinese medicine for treating silicosis |
| 05/18/2005 | CN1201740C Intermittent claudication therapeutic drugs comprising phyrroloazepines |
| 05/18/2005 | CN1201730C Treatment of emphysema using RAR selective retinoid agonists |
| 05/18/2005 | CN1201717C Composite for oxidation-dyeing keratin fibre and its dyeing method |
| 05/17/2005 | US6894177 Viricides; human immunodeficiency virus |
| 05/17/2005 | US6894168 Carbamoyl tetrahydropyridine derivatives |
| 05/17/2005 | US6894165 Imidazonaphthyridines |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894068 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 05/17/2005 | US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases |
| 05/17/2005 | US6894058 Administering statin drug |
| 05/17/2005 | US6894054 Central nervous system disorders; muscular disorders |
| 05/17/2005 | US6894052 Serotonergic receptor antagonist |
| 05/17/2005 | US6894051 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 05/17/2005 | US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives |
| 05/17/2005 | US6894047 Triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 05/17/2005 | US6894043 Benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
| 05/17/2005 | US6894042 Azabicyclic compounds for the treatment of disease |
| 05/17/2005 | US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
| 05/17/2005 | US6894036 4-dedimethylaminotetracycline derivatives |
| 05/17/2005 | US6894032 Or salt thereof |
| 05/17/2005 | US6894021 Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation |
| 05/17/2005 | US6893858 Human kcnq5 potassium channel, methods and compositions thereof |
| 05/17/2005 | US6893844 DNA encoding a new human hepatoma derived growth factor and producing method thereof |
| 05/17/2005 | US6893833 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes |
| 05/17/2005 | US6893659 Pharmaceutical composition for oral administration of a N-piperidino-3- pyrazolecarboxamide derivative, its salts and their solvates |
| 05/17/2005 | US6893642 Anticancer nutraceutical from spirulina |
| 05/17/2005 | US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 05/17/2005 | US6893636 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 05/17/2005 | US6893627 Method for treating type 2 diabetes with an extract of Artemisia |
| 05/17/2005 | CA2402712C Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease |
| 05/17/2005 | CA2306782C Isoquinolines as urokinase inhibitors |
| 05/17/2005 | CA2304987C Inhibition of an fgf-binding protein using ribozymes |
| 05/17/2005 | CA2267510C Process for manufacturing alpha-1l-adrenoceptor antagonists |
| 05/17/2005 | CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones |
| 05/17/2005 | CA2202390C Keratinocyte growth factor analogs |
| 05/17/2005 | CA2126327C Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 05/12/2005 | WO2005041995A1 α-GLUCOSIDASE ACTIVITY INHIBITOR |
| 05/12/2005 | WO2005041993A1 Use of extracts from the pelargonium species |
| 05/12/2005 | WO2005041858A2 Mucin production inhibitor |
| 05/12/2005 | WO2004029281A3 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 05/12/2005 | WO2004000858A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 05/12/2005 | WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/12/2005 | US20050101781 Eponemycin and epoxomicin analogs and uses thereof |
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101769 CD40-interacting and TRAF-interacting proteins |